WL
Willow Life Sciences, Inc.
SEC filingOther Health Care · Allston, MA
Amount raised$4Msold at filing
Total offering$4M
Investors in the raise19count reported to the SEC
FiledNov 6, 2025first sale May 29, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Catherine TadinaDirector
Mariia GrebenshchikovaDirector
Morgan MoncadaExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.